Effectiveness and Tolerability of Phentermine in Patients Under Bariatric Surgery

• Status: Completed
• Trial end date: 2020-04-01
• Target enrollment: 0
• Participant gender: All

Summary

Surgical management of Morbid Obesity is increasingly frequent. A low-calorie diet is recommended with the main goal of reducing intrahepatic fat infiltration, fat tissue and making easier the surgery. Information the use pharmacological interventions during the preoperative period in this population are rare.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Hospital Juarez de Mexico
• Treatments: Phentermine

Criteria

Inclusion Criteria:

• Women and men

• >18 years and <55 years old.

• Diagnosis of obesity grade II with comorbidities

• Diagnosis of obesity grade III with or without comorbidities

• Approved to bariatric surgery by an interdisciplinary committee

• Having signed the Informed consent form

Exclusion Criteria:

• Use of addictive substances

• Inability or lack of understanding to achieve lifestyle and behaviour changes

• Mental disease

• Severe Pulmonary disease

• Giant Hiatal hernia, gastric or duodenal ulcer

• Unstable coronary artery disease

• Portal hypertension or esophageal varices

• Surgical or anesthetic high risk